Objective: To probe into the problems of Chinese patent medicine for children and put forward improvement measures through the investigation of current status of Chinese patent medicine for children in the National Basic Medical Insurance

Occupational Injury Insurance and Maternity Insurance Catalogue (2020 Edition) (hereinafter referred to as the 2020 Edition of Medical Insurance Catalogue). Methods: Taking the instructions of 75 kinds of Chinese patent medicine for children included in the 2020 Edition of Medical Insurance Catalogue as the research object

the information in the instructions was collected

counted and analyzed. Results: In the 2020 Edition of Medical Insurance Catalogue

Chinese patent medicine for children were mainly used for internal medicine (85.33%). The number of preparation components was mainly from 3 to 10 (58.67%). There were 34 kinds of drugs containing toxic components

11 kinds of which were over the counter (OTC). The proportions of adverse drug reactions

contraindications

cautions and drug interactions labeled “not clear in the instructions were respectively 74.67%

78.67%

21.33% and 65.33%. Conclusion: The instructions for Chinese patent medicine for children are not perfect enough to provide safe and rational drug use information for children

so it is urgent to further improve the connotation of the instructions. It is suggested that the completeness of instructions should be considered as one of the indicators for the inclusion of drugs in the national medical insurance catalogue.